Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Guangdong Hanfei Hospital Investment is a Chinese healthcare services company focused on medical aesthetics and hospital/clinic investment and management. The entity was previously named Guangdong Pengai Hanfei Hospital Management and later renamed Guangdong Hanfei Investment Management before adopting its current name. It appears to operate as the investment and management vehicle behind the Hanfei medical aesthetics network in Guangdong, with interests in cosmetic hospitals and outpatient aesthetic clinics. The company is not a drug-development biotech or pharma company; rather, it is a commercially operating provider and manager of aesthetic healthcare assets. Publicly available information indicates it has been active since 2015 and has been affiliated with Jinfa Labi through equity investment and partial ownership transactions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Guangdong Hanfei Hospital Investment.